Companies · Healthtech

Virta Health Corp.

SAN FRANCISCO · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on Virta Health Corp. — recommendation, valuation, rhythm, risks.
$122.0M
Total raised · real
2
Rounds
3.2×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Wed Aug 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Virta Health Corp. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.19× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Virta Health Corp. is one of 2138 Healthtech companies tracked from SAN FRANCISCO. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
31
Investors (latest)
2019-08-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries B · 2016-07-05 Raised $29M (real) Modeled valuation $713M (est)$29M$713MSeries B2016Series C · 2019-08-21 Raised $93M (real) Modeled valuation $2.4B (est)$93M$2.4BSeries C2019+$93MCumulative $122M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$28.8M · 2016
Series C$93.2M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$2.4B
Base estimate est.
$338.7M
Conservative case
$6.3B
Upside case
$621.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $713.2M · 2016-07-052016Series C · modeled $2.4B · 2019-08-212019
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
6.0 yr
Elapsed time used
6.9 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
38 mo
Avg between rounds
$39.0M/yr
Capital velocity
10.0 yr
On record since
2016
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 27× above median
This company$122.0M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 2.0× above median
This company$93.2M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 71× above median
This company$2.4B
Sector median$33.8M

Raised more than 96% of sector peers (real $). Modeled value above 99% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 33.

This companyCohort peer
$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Fresenius Medical Care Voorhees, LLC · Series C Raised $71.1M · modeled $1.8B (est)Clear Health Pass Holdings LLC · Series C Raised $100.0M · modeled $1.8B (est)Zealth, Inc. · Series C Raised $95.0M · modeled $1.7B (est)Jawbone Health Hub, Inc. · Series C Raised $65.4M · modeled $1.7B (est)Boston Health Economic Holdings, LLC · Series C Raised $63.0M · modeled $1.6B (est)PWN Health Holdings, Inc. · Series C Raised $61.8M · modeled $1.5B (est)Quartet Health, Inc. · Series C Raised $127.0M · modeled $1.4B (est)Workit Health, Inc. · Series C Raised $87.9M · modeled $1.4B (est)Ajax Health II LLC · Series C Raised $51.0M · modeled $1.3B (est)Eden Health, Inc. · Series C Raised $73.4M · modeled $1.3B (est)NeuSpera Medical Inc. · Series C Raised $88.6M · modeled $1.3B (est)Virta Health Corp. (this company) Raised $122.0M · modeled $2.4B (est)Virta Health Corp.
CompanyStageRaised · realValue · estvs peer med.
Virta Health Corp. this companySeries C$122.0M$2.4B2.19×
Fresenius Medical Care Voorhees, LLCSeries C$71.1M$1.8B1.67×
Clear Health Pass Holdings LLCSeries C$100.0M$1.8B1.67×
Zealth, Inc.Series C$95.0M$1.7B1.55×
Jawbone Health Hub, Inc.Series C$65.4M$1.7B1.54×
Boston Health Economic Holdings, LLCSeries C$63.0M$1.6B1.48×
PWN Health Holdings, Inc.Series C$61.8M$1.5B1.39×
Quartet Health, Inc.Series C$127.0M$1.4B1.28×
Workit Health, Inc.Series C$87.9M$1.4B1.27×
Ajax Health II LLCSeries C$51.0M$1.3B1.20×
Eden Health, Inc.Series C$73.4M$1.3B1.19×
NeuSpera Medical Inc.Series C$88.6M$1.3B1.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$28.8M2016-07-05$159.9M$713.2M85%
Series C$93.2M2019-08-21$621.3M$2.4B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$28.8M2016-07-05
    • First recorded raise — entered as Series B.
    • 50 investors on this round.
  2. Series C$93.2M2019-08-21
    • Raised again after 38 mo — slower than the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
    • 31 investors on this round.
Intelligence
2022 ~Q4
Modeled next raise · ~38mo cadence
$279.6M
Modeled next size est.range $181.7M$447.3M
3.2×
Last step-up
$39.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Robert Kocher4 other2016-07
Donald Berwick2 other2019-08
Greg Waldorf2 other2019-08
Sami Inkinen2016-07
Stephen Phinney2016-07
Registry & provenance

Virta Health Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1680065
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Devoted Health, Inc.HealthtechSeries C$62.0M$1.6Bnetwork1 shared operator · same sector · same stage
Accompany Health, Inc.HealthtechSeries C$56.3M$680.1Mnetwork1 shared operator · same sector · same stage
Quartet Health, Inc.HealthtechSeries C$127.0M$1.4Bsame sector · same stage
Entellus Medical IncHealthtechSeries C$115.0M$1.3Bsame sector · same stage
Gt Medical Technologies, Inc.HealthtechSeries C$114.5M$396.2Msame sector · same stage
Tabula Rasa HealthCare, Inc.HealthtechSeries C$109.3M$572.7Msame sector · same stage
All Inspire Health, Inc.HealthtechSeries C$137.4M$549.8Msame sector · same stage
Eleanor Health Holdings, LlcHealthtechSeries C$138.0M$210.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Vitus Animal Health, Inc.HealthtechSeries A$166.7M85%
Vironix Health Inc.HealthtechSeed$7.2M85%
Cvr Medical Corp.HealthtechPre-Seed$13.6M85%
Health Warrior, Inc.HealthtechSeries A$112.9M84%
HealthReveal, Inc.HealthtechSeries B$659.2M84%
Vsee Health, Inc.HealthtechSeries A$2.7M84%
Healthcare, Inc.HealthtechSeries D+$4.0B83%
GVC Health Technology Holdings Inc.HealthtechPre-Seed$10.9M83%
Frequently asked
How much funding has Virta Health Corp. raised?
Virta Health Corp. has raised approximately $122.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Virta Health Corp.'s estimated valuation?
Provath's modeled valuation for Virta Health Corp. is approximately $2.4B (modeled range $338.7M–$6.3B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Virta Health Corp. at?
Virta Health Corp.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Aug 21.
What does Virta Health Corp. do and where is it based?
Virta Health Corp. operates in the Healthtech sector, based in SAN FRANCISCO.
Explore related

See where Virta Health Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Virta Health Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.